|
|
Volumn 378, Issue , 1995, Pages 565-569
|
|
Vaccine adjuvancy: A new potential area of development for GM-CSF
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HEPATITIS B VACCINE;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
IMMUNOLOGICAL ADJUVANT;
INFLUENZA VACCINE;
PLACEBO;
RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
VACCINE;
ANTIBODY TITER;
ANTIGEN PRESENTATION;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG INDICATION;
HUMAN;
IMMUNOREGULATION;
INTRAMUSCULAR DRUG ADMINISTRATION;
PRIORITY JOURNAL;
SEROCONVERSION;
SUBCUTANEOUS DRUG ADMINISTRATION;
T LYMPHOCYTE ACTIVATION;
VACCINATION;
HUMAN IMMUNODEFICIENCY VIRUS;
|
|
EID: 0029164491
PISSN: 00652598
EISSN: None
Source Type: Book Series
DOI: 10.1007/978-1-4615-1971-3_127 Document Type: Conference Paper |
|
Times cited : (13)
|
|
References (0)
|
